[A case of heterogeneous emphysema treated with bronchoscopic thermal vapour ablation(BTVA)]

Bronchoscopic thermal vapour ablation (BTVA), recommended by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) as a respiratory intervention technique, has not been widely implemented in China for the treatment of severe chronic obstructive pulmonary disease (COPD) patients. Here, we reported a case of a 78-year-old man with upper lobe heterogeneous emphysema who was treated with BTVA. This therapy resulted in clinically significant improvements in pulmonary function, quality of life, and exercise tolerance. No serious adverse events were observed.